356 related articles for article (PubMed ID: 4591596)
1. [Identification of the carrier state in the severe recessive X-linked muscular dystrophy (Duchenne type). I. Assay of activated serum creatine kinase activity in serum (author's transl)].
Rotthauwe HW; Kowalewski S
Z Kinderheilkd; 1973 Nov; 115(4):333-42. PubMed ID: 4591596
[No Abstract] [Full Text] [Related]
2. [Estimation of the probability of heterozygosity in Duchenne-type progressive muscular dystrophy].
Guízar Vázquez J; Navarrete Cadena C; Rico R; Mora G; Zavala C
Bol Med Hosp Infant Mex; 1981; 38(1):23-33. PubMed ID: 7284070
[TBL] [Abstract][Full Text] [Related]
3. [Muscle LDH isoenzymes in neuromuscular diseases and in carriers of recessive X-linked muscular dystrophy (duchenne)].
Kowalewski S; Rotthauwe HW
Z Kinderheilkd; 1972; 113(1):55-70. PubMed ID: 5056500
[No Abstract] [Full Text] [Related]
4. Carrier detection in X-linked muscular dystrophy.
Walton JN
J Genet Hum; 1969 Oct; 17(3):497-510. PubMed ID: 5387424
[No Abstract] [Full Text] [Related]
5. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.
Sumita DR; Vainzof M; Campiotto S; Cerqueira AM; Cánovas M; Otto PA; Passos-Bueno MR; Zatz M
Am J Med Genet; 1998 Dec; 80(4):356-61. PubMed ID: 9856563
[TBL] [Abstract][Full Text] [Related]
6. Carrier detection and genetic counselling in Duchenne muscular dystrophy: a follow-up study.
Hutton EM; Thompson MW
Can Med Assoc J; 1976 Oct; 115(8):749-52. PubMed ID: 974964
[TBL] [Abstract][Full Text] [Related]
7. [A family of scapula-back type of x-linked recessive muscular dystrophy].
Ji XW
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Jun; 22(3):136-8, 190. PubMed ID: 2591265
[TBL] [Abstract][Full Text] [Related]
8. Creatine-kinase and pyruvate-kinase activities in normal children: implications in Duchenne muscular dystrophy carrier detection.
Passos MR; Gonzalez CH; Zatz M
Am J Med Genet; 1985 Oct; 22(2):255-62. PubMed ID: 4050856
[TBL] [Abstract][Full Text] [Related]
9. Genetic counseling in Becker type X-linked muscular dystrophy. II: Practical considerations.
Grimm T
Am J Med Genet; 1984 Aug; 18(4):719-23. PubMed ID: 6486170
[TBL] [Abstract][Full Text] [Related]
10. The manifesting carrier in Duchenne muscular dystrophy.
Moser H; Emery AE
Clin Genet; 1974; 5(4):271-84. PubMed ID: 4854942
[No Abstract] [Full Text] [Related]
11. [Biochemical, histological and clinical findings in carriers of Duchenne-type progressive muscular dystrophy].
Moser H; Mumenthaler M; Wiesmann U
Schweiz Med Wochenschr; 1971 Apr; 101(15):537-42. PubMed ID: 5576948
[No Abstract] [Full Text] [Related]
12. Platelet diphenoloxidases in progressive muscular dystrophy (P.M.D.).
Dèmos J
Clin Genet; 1973; 4(2):79-90. PubMed ID: 4199873
[No Abstract] [Full Text] [Related]
13. Duchenne muscular dystrophy and idiopathic hyperCKemia in a family causing confusion in genetic counselling.
Bushby K; Goodship J; Haggerty D; Heald A; Walls T
Am J Med Genet; 1996 Dec; 66(2):237-8. PubMed ID: 8958338
[No Abstract] [Full Text] [Related]
14. Muscular dystrophy. Part II: Serum enzymes in relatives of cases of the Duchenne muscular dystrophy.
Narayanan I; Ramakrishna Rao P; Balakrishnan S; Subrahmanyam K
Indian J Med Res; 1974 Apr; 62(4):605-11. PubMed ID: 4435869
[No Abstract] [Full Text] [Related]
15. Change of serum creatine phosphokinase activity after exercise in Duchenne type of progressive muscular dystrophy.
Nakane K
Nagoya Med J; 1972 Feb; 17(3):203-16. PubMed ID: 5050757
[No Abstract] [Full Text] [Related]
16. [Serum creatine phosphokinase activity in Duchenne-type muscular dystrophy and carriers].
Kato F; Takahashi K
Iryo; 1968 Dec; 22(12):1386-91. PubMed ID: 5717705
[No Abstract] [Full Text] [Related]
17. DUCHEN: an interactive computer program for calculating heterozygosity (carrier) risks in X-linked recessive lethal diseases, and its application in Duchenne muscular dystrophy.
Andrews DF; Brasher PM; Manchester KE; Percy ME; Rusk AC; Soltan HC; Trueman DW
Am J Med Genet; 1986 Oct; 25(2):211-8. PubMed ID: 3777018
[TBL] [Abstract][Full Text] [Related]
18. Improved detection of Duchenne muscular dystrophy heterozygotes using discriminant analysis of creatine kinase levels.
Muir WA; Knoke J; Martin A; Vignos P; McErlean A
Am J Med Genet; 1983 Jan; 14(1):125-34. PubMed ID: 6829600
[TBL] [Abstract][Full Text] [Related]
19. [Genetic counseling in myotonia and muscular dystrophy].
Becker PE
Internist (Berl); 1978 Aug; 19(8):475-81. PubMed ID: 357337
[No Abstract] [Full Text] [Related]
20. [An unusual form of benign hereditary recessive x-chromosomal muscular dystrophy].
Rotthauwe HW; Beyer H
Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):410. PubMed ID: 5523692
[No Abstract] [Full Text] [Related]
[Next] [New Search]
